R&D/Clinical Trials

Evolution of Prostate Cancer Treatment Gathers Speed

April 06, 2020

Amy Butcher evaluates the current treatment options for prostate cancer and the looks to the future as clinical outcomes evolve.

COVID-19: Therapeutics Under Investigation

March 31, 2020

Janita Good looks at some of the therapeutics currently under investigation and the issues they have highlighted in the context of a pandemic.

Blood Feud Divides Europe Over Plasma Shortfalls

March 09, 2020

Pharmaceutical Executive

The collection of source plasma for new therapies igniting debate.

Improving the Link from Lab to Physician

February 19, 2020

Pharmaceutical Executive

How current barriers along the roadway between biomarker testing and drug prescribing can affect decision-making for precision medicines.

The Risks and Rewards of Expedited Review

February 09, 2020

Pharmaceutical Executive

Weighing new strategies to accelerate biomedical product development.

The Roots and Rise of Cell and Gene Therapy

February 08, 2020

Pharmaceutical Executive

Continued investment will mean new cures in a new decade.

Politics & Pricing to Shape Pharma Prospects in 2020

January 13, 2020

Pharmaceutical Executive

Challenges will mount to established models for researching, developing, and marketing new therapies.

AstraZeneca's CVRM Path

January 13, 2020

AstraZeneca's Joris Silon outlines the company's efforts in CVRM (Cardiovascular, Renal and Metabolism) and the potential impact on type-2 diabetes and chronic kidney disease of SGLT2 inhibitors such as Forxiga.

Pharm Exec’s 2020 Pipeline Report

December 05, 2019

Pharrm Exec's 2020 Pipeline Report

Pipeline Extra: Mastering the Microbiome

December 03, 2019

As the microbiome "moves into the mainstream," Pharm Exec looks at how industry activity in the space is heating up.